Should Organs at Risk (oars) Be Prioritized over Target Volume Coverage in Stereotactic Ablative Radiotherapy (SABR) for Oligometastases? a Secondary Analysis of the Population-Based Phase II SABR-5 Trial.
RADIOTHERAPY AND ONCOLOGY（2023）
关键词
Oligometastasis,Oligometastases,Stereotactic ablative radiotherapy,Stereotactic body radiation therapy,SABR,SABR-5,SBRT,Coverage compromise index
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要